(Oslo 17. 11.2014) In connection with the results of the Vacc-4x + IMiD study (Kill & Boost study) announced this morning Bionor Pharma ASA (OSE:BIONOR) will hold a webcast at 08.20 CET 17 November 2014.

A presentation of the key results will be available at the Company's website at this time www.bionorpharma.com. Presentation of the key results by CEO Anker Lundemose, CFO Synne Røine and Dr. Shahin Gharakhanian will be webcasted at 08.20.

Schedule for the webcast /teleconference 17 November
08.15 - Log in to the webcast-link, and/or use conference call numbers
08.20 - Presentation of key results by Bionor Pharma CEO Anker Lundemose and CFO Synne Røine

The webcast will be available at http://www.media-server.com/m/p/7au6zwzb 

Link til presentasjon

Conference Call numbers
Use the following numbers to participate in the Q&A session at the end of the presentation or listen to the webcast by telephone:
Participants, Local - London, United Kingdom: +44(0) 20 3427 1906
Participants, Local - NY, USA: +1 212 444 0412
Participants, Local - Oslo, Norway: +47 2316 2787
Participants, Local - Copenhagen, Denmark: +45 32 71 16 60
Participants, Local - Stockholm, Sweden: +46 (0)8 5033 6539
Confirmation Code: 7065915
Participants will have to quote the above code when dialing into the conference.

One week replay - conference call replay numbers
Webcast is available for replay at the following numbers:
Local - Copenhagen, Denmark: +45 32 71 09 13
Local - London, United Kingdom: +44 (0)20 34 27 0598
Local - NY, USA: +1 347 366 9565
Local - Oslo, Norway: +47 2100 0498
Local - Stockholm, Sweden:+46 (0)8 5051 3897
Replay Pass code: 7065915 

Bionor Pharma ASA
Synne Røine
CFO
Tel +47 99 22 98 92 

distributed by